SenesTech Future Growth

Future criteria checks 2/6

SenesTech is forecast to grow earnings and revenue by 16.7% and 44.5% per annum respectively while EPS is expected to grow by 63.5% per annum.

Key information

16.7%

Earnings growth rate

63.5%

EPS growth rate

Pharmaceuticals earnings growth21.4%
Revenue growth rate44.5%
Future return on equityn/a
Analyst coverage

Low

Last updated28 Dec 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BST:SE81 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268-6-4N/A1
12/31/20255-7-6N/A1
12/31/20242-8-7N/A1
12/31/20231-8-2N/A1
9/30/20231-8-8-8N/A
6/30/20231-9-8-8N/A
3/31/20231-9-9-9N/A
12/31/20221-10-9-9N/A
9/30/20221-10-8-8N/A
6/30/20221-10-8-8N/A
3/31/20221-9-8-8N/A
12/31/20211-8-8-8N/A
9/30/20211-8-8-8N/A
6/30/20210-8-8-8N/A
3/31/20210-7-7-7N/A
12/31/20200-8-7-7N/A
9/30/20200-9-8-7N/A
6/30/20200-10-8-8N/A
3/31/20200-10-8-8N/A
12/31/20190-10-8-8N/A
9/30/20190-10-8-8N/A
6/30/20190-10-9-8N/A
3/31/20190-12-9-9N/A
12/31/20180-12-9-9N/A
9/30/20180-12-9-9N/A
6/30/20180-12-8-8N/A
3/31/20180-11-9-8N/A
12/31/20170-12-10-9N/A
9/30/20170-14-11-10N/A
6/30/20170-13N/A-10N/A
3/31/20170-12N/A-9N/A
12/31/20160-11N/A-7N/A
9/30/20160-14N/A-5N/A
6/30/20160-20N/A-4N/A
3/31/20160-20N/A-4N/A
12/31/20150-18N/A-4N/A
12/31/20140-7N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SE81 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SE81 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SE81 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SE81's revenue (44.5% per year) is forecast to grow faster than the German market (4.8% per year).

High Growth Revenue: SE81's revenue (44.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SE81's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.